Deciphera Pharmaceuticals (DCPH) Earnings
|
Expand Research on DCPH
| Next EPS Date | 5/1/24 | EPS Growth Rate | +8.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.9% | Revenue Growth Rate | +37.7% |
| Average % Move 1-Wk after EPS | +10.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/1/24 | Q124 | N/A | -$0.55 | N/A | N/A | $45.99M | N/A | N/A | N/A | ||
| 2/6/24 | Q423 | -$0.54 | -$0.59 | +$0.05 | $48.3M | $45.81M | N/A |  | | Details | |
10/30/23  |
Q323 | -$0.58 | -$0.61 | +$0.03 | $43.31M | $39.44M | N/A | | | Details | |
| 11/8/23 | Q323 | N/A | -$0.61 | N/A | N/A | $39.44M | N/A | N/A | N/A | ||
| 8/3/23 | Q223 | N/A | -$0.62 | N/A | N/A | $36.1M | N/A | N/A | N/A | ||
| 8/9/23 | Q223 | -$0.57 | -$0.62 | +$0.05 | $38.3M | $36.1M | N/A | | | Details | |
| 5/3/23 | Q123 | -$0.60 | -$0.59 | -$0.01 | $33.4M | $35.69M | N/A | | | Details | |
| 2/7/23 | Q422 | -$0.60 | -$0.57 | -$0.03 | $36.35M | $35.67M | N/A | | | Details |
